Lung and respiratory capabilities.
Fortrea provides access to an extensive inhalation team and facility, medical device development and strategies for clinical trials and post-market reimbursement for organizations pursuing a treatment compound or device for respiratory and lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancers, cystic fibrosis (CF) or idiopathic pulmonary fibrosis.